Kinegic Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.00 M
as on 10-12-2024
- Revenue 115.03%
(FY 2022)
- Profit 158.72%
(FY 2022)
- Ebitda 88.60%
(FY 2022)
- Net Worth 135.09%
(FY 2022)
- Total Assets 126.01%
(FY 2022)
About Kinegic Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Vijaya Yarapatni and Sitalaxmi Yerrapatni serve as directors at the Company.
- CIN/LLPIN
U33119TG2020PTC140375
- Company No.
140375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Kinegic Pharmaceuticals Private Limited offer?
Kinegic Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections.
Who are the key members and board of directors at Kinegic Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaya Yarapatni  | Director | 21-May-2020 | Current |
| Sitalaxmi Yerrapatni | Director | 21-May-2020 | Current |
Financial Performance of Kinegic Pharmaceuticals.
Kinegic Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 115.03% increase. The company also saw a substantial improvement in profitability, with a 158.72% increase in profit. The company's net worth Soared by an impressive increase of 135.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kinegic Pharmaceuticals?
Unlock access to Kinegic Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vin Precast Private LimitedActive 12 years 18 daysVijaya Yarapatni and Sitalaxmi Yerrapatni are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 22 Nov 2023 | ₹3.00 M | Open |
How Many Employees Work at Kinegic Pharmaceuticals?
Kinegic Pharmaceuticals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kinegic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kinegic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
